Zyversa Therapeutics logo

Zyversa Therapeutics Share Price Today

(NASDAQ: ZVSA)

Zyversa Therapeutics share price is $0.94 & ₹81.75 as on 6 Mar 2025, 2.30 'hrs' IST

$0.94

-0.14

(-12.58%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Zyversa Therapeutics share price in Dollar and Rupees. Guide to invest in Zyversa Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Zyversa Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Zyversa Therapeutics share price movements

  • Today's Low: $0.94
    Today's High: $1.13

    Day's Volatility :16.81%

  • 52 Weeks Low: $0.94
    52 Weeks High: $10.80

    52 Weeks Volatility :91.3%

Zyversa Therapeutics (ZVSA) Returns

PeriodZyversa Therapeutics IncIndex (Russel 2000)
3 Months
4.8%
0.0%
6 Months
-61.43%
0.0%
1 Year
-85.95%
0.0%
3 Years
-99.96%
-11.6%

Zyversa Therapeutics (ZVSA) Key Statistics

in dollars & INR

Previous Close
$1.08
Open
$1.02
Today's High
$1.1299
Today's Low
$0.94
Market Capitalization
$2.7M
Today's Volume
$58.2K
52 Week High
$10.8
52 Week Low
$0.94
Revenue TTM
$0.0
EBITDA
$-9.6M
Earnings Per Share (EPS)
$506.03
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-159.59%

How to invest in Zyversa Therapeutics Stock (ZVSA) from India?

It is very easy for Indian residents to invest directly in Zyversa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zyversa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zyversa Therapeutics or ZVSA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zyversa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zyversa Therapeutics shares which would translate to 0.925 fractional shares of Zyversa Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zyversa Therapeutics, in just a few clicks!

Returns in Zyversa Therapeutics (ZVSA) for Indian investors in Rupees

The Zyversa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Zyversa Therapeutics investment value today

Current value as on today

₹17,186

Returns

₹82,814

(-82.81%)

Returns from Zyversa Therapeutics Stock

₹87,776 (-87.78%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Zyversa Therapeutics (ZVSA)

-84%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Zyversa Therapeutics Stock from India on INDmoney has decreased by -84% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Zyversa Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Zyversa Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Zyversa Therapeutics Stock (ZVSA)

What analysts predicted

Upside of 2027.66%

Target:

$20.00

Current:

$0.94

Insights on Zyversa Therapeutics Stock (Ticker Symbol: ZVSA)

  • Price Movement

    In the last 6 months, ZVSA stock has moved down by -61.4%
  • ZVSA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 149.7%

Zyversa Therapeutics Technicals Summary

Sell

Neutral

Buy

Zyversa Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Zyversa Therapeutics (ZVSA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zyversa Therapeutics Inc logo
-20.59%
-61.43%
-85.95%
-99.96%
-99.96%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zyversa Therapeutics Inc logo
0.0
0.0
NA
0.0
-1.6
-0.23
NA
6.54
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zyversa Therapeutics Inc logo
Buy
$2.7M
-99.96%
0.0
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Zyversa Therapeutics

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is headquartered in Weston, Florida.
Organization
Zyversa Therapeutics
Employees
7
CEO
Mr. Stephen C. Glover
Industry
Miscellaneous

Management People of Zyversa Therapeutics

NameTitle
Mr. Stephen C. Glover
Co-Founder, Chairman, CEO & President
Mr. Peter Wolfe
CFO & Secretary
Ms. Karen A. Cashmere
Chief Commercial Officer
Ms. Melda Uzbil O'connell
Senior Vice President of Corporate Development
Dr. Pablo A. Guzman FACC, M.D.
Chief Medical Officer, Senior VP of Medical Affairs & Chairman of Renal Scientific Advisory Board

Important FAQs about investing in ZVSA Stock from India :

What is Zyversa Therapeutics share price today?

Zyversa Therapeutics share price today stands at $0.94, Open: $1.02 ; Previous Close: $1.08 ; High: $1.13 ; Low: $0.94 ; 52 Week High: $10.80 ; 52 Week Low: $0.94.

The stock opens at $1.02, after a previous close of $1.08. The stock reached a daily high of $1.13 and a low of $0.94, with a 52-week high of $10.80 and a 52-week low of $0.94.

Can Indians buy Zyversa Therapeutics shares?

Yes, Indians can invest in the Zyversa Therapeutics (ZVSA) from India.

With INDmoney, you can buy Zyversa Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Zyversa Therapeutics at zero transaction cost.

How can I buy Zyversa Therapeutics shares from India?

It is very easy to buy Zyversa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zyversa Therapeutics (ZVSA) be purchased?

Yes, you can buy fractional shares of Zyversa Therapeutics with INDmoney app.

What are the documents required to start investing in Zyversa Therapeutics stocks?

To start investing in Zyversa Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Zyversa Therapeutics Stock (ZVSA)?

Today’s highest price of Zyversa Therapeutics (ZVSA) is $1.13.

Today’s lowest price of Zyversa Therapeutics (ZVSA) is $0.94.

What is today's market capitalisation of Zyversa Therapeutics?

Today's market capitalisation of Zyversa Therapeutics ZVSA is 2.7M

What is the 52 Week High and Low Range of Zyversa Therapeutics Stock (ZVSA)?

  • 52 Week High

    $10.80

  • 52 Week Low

    $0.94

What are the historical returns of Zyversa Therapeutics (ZVSA)?

  • 1 Month Returns

    -20.59%

  • 3 Months Returns

    -61.43%

  • 1 Year Returns

    -85.95%

  • 5 Years Returns

    -99.96%

Who is the Chief Executive Officer (CEO) of Zyversa Therapeutics ?

Mr. Stephen C. Glover is the current Chief Executive Officer (CEO) of Zyversa Therapeutics.